Healthcare - Biotechnology - NASDAQ - US
$ 56.23
-5.92 %
$ 3.46 B
Market Cap
-13.02
P/E
Price Target
Average
8.84%
Revenue Forecast
Estimate
86.31%
EBIT
Estimate
--0.30%
Net Income
Estimate
39.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rhythm Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RYTM of $61.2 , with forecasts ranging from a low of $55 to a high of $64 .
RYTM Lowest Price Target
Wall Street Target
55 USD
-2.19%
RYTM Average Price Target
Wall Street Target
61.2 USD
8.84%
RYTM Highest Price Target
Wall Street Target
64 USD
13.82%
REVENUE FORECAST
Revenue Forecast Chart RYTM
EBIT FORECAST
EBIT Forecast Chart RYTM
NET INCOME FORECAST
Net Income Chart RYTM